BioSpace News Archive

Business

XtalPi and Signet Expand AI Drug Discovery Collaboration to Novel Cancer Target

Signet Therapeutics and XtalPi Inc., announced the expansion of their AI drug discovery collaboration to include a new first-in-class program against a novel cancer target identified by Signet.

October 27, 2021
·
5 min read
Genetown

Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Fall 2021 Conference

Organogenesis Holdings Inc. (Nasdaq: ORGO), today announced that the latest advanced wound care research on its PuraPly® AM, Affinity®, Apligraf®, and NuShield® product lines will be showcased at the 2021 Symposium on Advanced Wound Care (SAWC) Fall Conference.

October 27, 2021
·
4 min read
Business

BioHarvest Sciences Inc. Appoints Steven Lehrer to Its Board of Advisors

Steven Lehrer’s 40 years of Biotech experience enhances the board of advisors with expertise in pharmaceutical, biopharmaceutical, and biosimilar R&D.

October 27, 2021
·
4 min read
Pharm Country

New Report Will Help the FDA to Evaluate Future Treatments for Frontotemporal Degeneration

Today, The Association for Frontotemporal Degeneration (AFTD) released Frontotemporal Degeneration (FTD): A Voice of the Patient Report.

October 27, 2021
·
3 min read
Drug Development

Sorrento Announces Encouraging Results From Two Phase 2 Studies of Abivertinib For Treatment Of Hospitalized Severe COVID-19 Patients

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today positive preliminary results from two Phase 2 studies designed to identify the hospitalized patient population suffering from COVID-19-induced pneumonia and respiratory depression likely to respond to treatment with oral Abivertinib.

October 27, 2021
·
9 min read
Biotech Beach

The Lundquist Institute Receives $3 Million From NIH To Expand Male Contraception Study

The Lundquist Institute announced that its Male Contraceptive Efficacy Trial has received an additional $3 million from the National Institutes of Health to expand its work and recruit 120+ more couples.

October 27, 2021
·
4 min read
Drug Development

Inventiva announces the design of LEGEND, a Phase IIa combination trial with lanifibranor and SGLT2 inhibitor empagliflozin in patients with NASH and type 2 diabetes

Inventiva (Euronext Paris and Nasdaq: IVA), today announced the design of a proof-of-concept Phase IIa combination trial with its lead drug candidate lanifibranor and the SGLT2 inhibitor empagliflozin in patients with T2D and non-cirrhotic NASH.

October 27, 2021
·
10 min read
Business

SOPHiA GENETICS to Report Third Quarter 2021 Financial Results on November 10, 2021

SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the third quarter of 2021 before market open on Wednesday, November 10, 2021.

October 27, 2021
·
1 min read
Business

RxSight to Report Third Quarter 2021 Financial Results on November 10, 2021

RxSight, Inc., an ophthalmic medical device company, announced that it will report financial results for the third quarter of 2021 after the market close on Wednesday, November 10, 2021.

October 27, 2021
·
1 min read
BioMidwest

Align Technology Shares Findings From New Clinical Study That Validates the Significant Benefits of the iTero Element 5D Imaging System as an Aid in Detection and Monitoring of Interproximal Caries Lesions (Cavities)

Align Technology, Inc. announced the findings of a multi-center clinical study, “Reflected near-infrared light versus bite-wing radiography for the detection of proximal caries: a multicenter prospective clinical study conducted in private practices,” published in the peer-reviewed Journal of Dentistry.

October 27, 2021
·
5 min read